Natural compounds in gut microbiome show promise for inflammation treatment Researchers at the University of Toronto have discovered naturally occurring compounds in the gut microbiome that can potentially treat inflammation. These compounds interact with the constitutive androstane receptor (CAR), which plays a key role in processing foreign substances and managing inflammation in the liver. The study identified two specific compounds, diindolylmethane (DIM) and diindolylethane (DIE), which regulate CAR without the side effects associated with synthetic compounds, such as liver enlargement. These findings suggest a promising new approach to treating conditions like diabetes, fatty liver disease, and ulcerative colitis using components already present in the human gut. This research not only provides insights into new treatments but also underlines the significant role of gut-produced compounds in health management. Link to Study: https://lnkd.in/dzTpgbsX #microbiome #functionalnutrition #inflammation #guthealth #guthealthmatters #metabolichealth
Este estufio sugiere un nuevo enfoque prometedor para tratar afecciones como la diabetes, la enfermedad del hígado graso y la colitis ulcerosa utilizando componentes ya presentes en el intestino humano. Esta investigación no solo proporciona información sobre nuevos tratamientos, sino que también subraya el importante papel de los compuestos producidos por el intestino en la gestión de la salud.
There are many more than thise two!
Owner, laxmi biotech
5mo🥦🙏🥕🥑🍇Thanks for sharing 🫐🥒🍒👍🥭🍏🍓🥝